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Development of diabetic nephropathy in the Milan Normoten-
sive Strain, but not in the Milan Hypertensive Strain: Possible
permissive role of hemodynamics.
Background. Rats of the Milan normotensive strain de-
velop spontaneous glomerulosclerosis, whereas those of the
Milan hypertensive strain are resistant to renal disease, pos-
sibly due to intrarenal artery hypertrophy protecting from
systemic hypertension. To assess the role of hemodynamic ver-
sus metabolic factors in diabetic nephropathy, we investigated
whether streptozotocin-induced diabetes accelerates glomeru-
losclerosis in Milan normotensive and/or removes (the hemo-
dynamic) protection in Milan hypertensive rats by reducing
preglomerular vascular resistance.
Methods. Diabetic and nondiabetic Milan normotensive,
hypertensive, and progenitor Wistar rats were followed for
6 months for the assessment of renal function and structure.
Results. Proteinuria increased in nondiabetic and diabetic
normotensive and, to a lesser extent, in diabetic Wistar, but not
hypertensive rats. Serum creatinine increased and creatinine
clearance decreased in nondiabetic and diabetic normotensive
rats at 6 months. At 1.5 months, diabetic normotensive, but not
hypertensive rats showed increased glomerular filtration rate
and filtration fraction, suggesting glomerular hypertension. Di-
abetic nephropathy was detected in diabetic normotensive and
Wistar, but not hypertensive rats. Glomerular extracellular ma-
trix and TGF-b mRNA levels increased with diabetes (and age)
in normotensive, but not hypertensive rats. Arterioles and in-
terlobular arteries showed increased media thickness in hyper-
tensive versus normotensive rats, with diabetes reducing it only
in the normotensive.
Conclusion. These data show that Milan hypertensive rats
are not susceptible to diabetic nephropathy, at variance with
glomerulosclerosis-prone Milan normotensive rats, thus indi-
cating the importance of genetic background. Our study sug-
gests that the nature of this (genetic) protection might be
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hemodynamic, with intrarenal artery hypertrophy preventing
diabetes-induced loss of autoregulation.
Hyperglycemia plays a central role in the initiation and
progression of diabetic nephropathy, as shown by its pre-
vention or retardation by strict metabolic control [1, 2].
However, the familiar clustering of this complication [3]
indicates that it is modulated by genetic factors, though
no single gene has so far been identified as being able to
confer predisposition [4].
The injurious effects of hyperglycemia have been at-
tributed to various biochemical and metabolic conse-
quences of it, including the increased glucose flux through
the polyol and hexosamine pathways, protein kinase C ac-
tivation, nonenzymatic glycation, and oxidative stress [5].
However, several observations suggest that glomerular
injury induced by diabetes is dependent on the hemody-
namic changes occurring in the glomerular microvascu-
lature as a consequence of hyperglycemia and ultimately
resulting in increased glomerular capillary hydraulic pres-
sure [6]. Whether these indirect (hemodynamic) actions
of hyperglycemia prevail over its direct (metabolic) ef-
fects or vice versa is still unclear [7]. A central role for
glomerular hypertension in the pathogenesis of diabetic
nephropathy was postulated on the basis of experiments,
showing that decrease of glomerular capillary pressure by
blockade of the renin-angiotensin system and/or reduc-
tion of protein intake prevented or reversed proteinuria
and glomerular lesions in diabetic rats [8, 9]. However, the
ability of both interventions to directly inhibit TGF-b up-
regulation and consequent extracellular matrix (ECM)
overproduction [10] raises the possibility that their thera-
peutic benefit is independent, at least partly, of the hemo-
dynamic effect.
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Two genetically related rat strains derived from a
common Wistar (WS) ancestor, the Milan normotensive
strain (MNS) and the Milan hypertensive strain (MHS),
display different susceptibility to develop glomeruloscle-
rosis and arterial hypertension.
The MNS rats develop an age-dependent focal and seg-
mental glomerulosclerosis [11], similar to that occurring
in human subjects [12] and also in other rat strains, includ-
ing the progenitor WS rats, though at an older age [13].
Mechanisms underlying propensity to glomerulosclerosis
are poorly understood, since classic risk factors cannot be
identified [11, 14].
In contrast to the MNS, no glomerular disease oc-
curs in MHS rats, despite the presence of hypertension
[15], which originates from the kidney, since it can be
transmitted to MNS rats with renal transplantation [16].
Hypertension has been attributed, at least partly, to a
missense mutation of the a and b subunits of the ad-
ducin heterodimer, a protein participating in the assem-
bly of spectrin-actin cytoskeleton [17]. This mutation is
associated with altered cytoskeleton assembly, increased
expression of Na+/K+ ATPase, and up-regulation of
Na+/K+ pump activity of apical and basolateral mem-
branes of renal tubules [18]. The resulting sodium and
water retention would be compensated by an increase in
blood pressure, thereby triggering a structural autoregu-
latory response of preglomerular resistance vessels main-
taining hypertension [19]. This response was confirmed
by the marked hypertrophy of the intrarenal arteries, par-
ticularly the interlobular, detected in the MHS, which
may account for resistance to renal injury by protect-
ing glomerular capillaries toward systemic hypertension
[11].
The present study was aimed at assessing the role
of hemodynamic versus metabolic factors in the patho-
genesis of diabetic nephropathy by verifying whether
superimposition of chronic hyperglycemia is capable of
accelerating spontaneous glomerulosclerosis in the sus-
ceptible MNS rats and/or removing (the hemodynamic)
protection in the MHS rats via a reduction of preglomeru-
lar vascular resistance. To this end, we investigated the
effects of experimental diabetes of 6-month duration on
renal function and structure in MNS, MHS, and WS rats.
Additionally, in order to evaluate another microcircu-
latory district, possibly lacking of autoregulation, and
therefore not protected from the hemodynamic injury
in MHS rats, we assessed retinal microvascular apopto-
sis, together with glomerular cell apoptosis, as control.
Apoptosis is an early cellular event in diabetic retinopa-
thy at variance with retinal histologic changes that are not
fully expressed after 6 months of diabetes. Retinal apop-
tosis can be quantified in microvascular specimens in situ,
and is considered to play a major role in the formation
of acellular capillaries and subsequent retinal ischemia,
leading to neovascularization [20].
METHODS
Experimental design
Adult (aged 12 weeks, weighing ∼280 g) male MNS,
MHS, and WS rats were divided into the following groups:
time 0 control rats, which were killed immediately af-
ter initiating the study, and nondiabetic and diabetic rats,
which were sacrificed 3 and 6 months after diabetes in-
duction, with the exception of WS rats, which were all
killed at 6 months.
The Milan rats were obtained from Prassis Research
Institute sigma tau (Settimo Milanese, Milan, Italy),
whereas WS rats were purchased from Charles Rivers
Italia (Calco, Lecco, Italy). The experimental study was
approved by the local animal care committee.
Diabetes was induced by a single injection (via the cau-
dal vein) of 55 mg/kg streptozotocin body weight (Sigma
Chemical, St. Louis, MO, USA) in citrate buffer (pH 4.5)
[21]. The animals were housed and cared for in keep-
ing with the “Principles of laboratory animal care” (NIH
Publication no. 85–23, revised 1985) and European laws
and regulations, and received water and food ad libitum.
All diabetic animals were given supportive insulin treat-
ment (Ultratard, Novo Nordisk, Bagsvaerd, Denmark;
4 IU/kg body weight 1 to 3 times a week, based on body
weight measurements) to prevent ketosis without affect-
ing significantly glycemia. As previously reported [21],
less than 10% of diabetic rats showed spontaneous rever-
sal of diabetes or developed cancer as a consequence of
streptozotocin injection (cancer occurred also in 1 nondi-
abetic WS rat), and were excluded from the study. In ad-
dition, 1 rat from each diabetic group died before the end
of the study period due to uncontrolled hyperglycemia,
and each was also excluded.
Metabolic control was evaluated by measuring blood
glucose and body weight at regular intervals (weekly and
3 times a week, respectively) and glycated hemoglobin
at sacrifice. At 1.5-month intervals, rats were placed into
metabolic cages for 24 hours to collect urines for measur-
ing urine volume, proteinuria, and creatininuria. Before
sacrifice, a portion of the Milan rats were subjected to
direct measurement of blood pressure and heart rate. At
sacrifice, a blood sample was obtained, and then both kid-
neys were removed for the evaluation of renal structure,
glomerular cell apoptosis, and glomerular gene expres-
sion for the ECM components fibronectin, laminin B1,
and collagen IV a1 chain, and the prosclerotic cytokine
TGF-b1; the eyes were also sampled for the assessment
of retinal microvascular apoptosis. A different set of Mi-
lan rats underwent assessment of renal hemodynamics
at 1.5 months of diabetes duration, when hemodynamic
changes are usually detectable [8, 9].
Body weight, blood glucose, glycated hemoglobin,
serum creatinine, creatinine clearance, and kidney weight
were measured in all animals at the end of the study (i.e.,
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at time 0, 3 months, or 6 months); serum creatinine and
creatinine clearance were also assessed at 1.5 months.
Urine volume and proteinuria were measured longitudi-
nally in the 3-month and 6-month groups [i.e., urine sam-
ples were obtained (a) at time 0 from a few rats from the
3- and 6-month nondiabetic groups plus all the time 0 con-
trol rats; (b) at 1.5 and 3 months, from the 3- and 6-month
groups; (c) at 4.5 and 6 months from the 6-month groups
only (this is the reason for the larger number of animals
in these groups, as compared with time 0 and 3-month
groups)]. Morphologic examination of kidney tissue sec-
tions was performed in all animals, whereas morphomet-
ric analysis of renal structure, assessment of ECM and
TGF-b gene expression, evaluation of glomerular cell
and retinal microvascular apoptosis, and direct measure-
ment of blood pressure and heart rate were performed in
6 animals per group, carefully matched for body weight
and, in the case of diabetic animals, glycated hemoglobin,
in order to avoid bias due to differences in the severity of
metabolic derangement among the diabetic groups.
Metabolic and cardiovascular parameters
Body weights were measured three times a week and
served as a guide for supportive insulin treatment. Blood
glucose levels were measured biweekly by an automated
colorimetric instrument (Glucocard Memory 2; Menar-
ini Diagnostics, Florence, Italy) from blood obtained by
tail venipuncture. Glycated hemoglobin levels were as-
sessed by boronate affinity gel chromatography using the
Glyc-Affin GHb kit (PerkinElmer, Norwalk, CT, USA)
[21].
For blood pressure measurement [22], rats were anes-
thetized with urethane (1.2 g/kg body weight i.p.; Sigma),
maintained at 37◦C with a heating pad, and the tra-
chea was connected to a small rodent respirator for con-
tinuous ventilatory support. The left carotid artery was
cannulated with polyethylene tubing (PE50) filled with
heparinized saline solution (400 U/mL) and the cannula
was connected through a Statham P23 pressure trans-
ducer to a Grass 7P polygraph (Astro-Med, Milan, Italy)
for arterial blood pressure recording. Heart rate was mea-
sured beat-to-beat by tachographic conversion on a Grass
74P instrument (Astro-Med).
Renal function
Glomerular filtration barrier integrity was evaluated
by assessing total proteinuria using the Bradford dye-
binding protein assay kit (Pierce Chemical, Rockford, IL,
USA). Renal function was evaluated by assessing serum
creatinine and creatinine clearance; serum and urine cre-
atinine levels were measured by the Jaffe method [21].
For the assessment of renal hemodynamics [23], rats
were anesthetized with Inactin (80–100 mg/kg body
weight i.p.; Research Biomedical International, Natick,
MA, USA), placed on a thermoregulated table and tra-
cheostomized. The jugular vein and femoral artery were
cannulated (PE50) for infusion of a bicarbonate-saline
solution containing 5% inulin and continuous blood
pressure monitoring, respectively. The bladder was then
catheterized (PE90) through a suprapubic incision, and
the left kidney pedicle was carefully exposed to gain ac-
cess to the renal vein. After a 60-minute stabilization pe-
riod, the rats underwent at least 3 clearance periods with
timed collection of urine and withdrawal of an arterial
plasma sample. Blood was also collected from the renal
vein through a sharpened glass micropipette under micro-
scopic magnification. Urine and plasma inulin concentra-
tions were measured by the diphenylamine method, and
glomerular filtration rate (GFR) was calculated accord-
ing to standard formulas. Filtration fraction (FF) was es-
timated by inulin renal extraction using the formula FF =
[(A−V)/A] × 100, where A and V represent the arterial
and renal venous concentration of inulin. Renal plasma
flow (RPF) was calculated by the ratio between GFR and
FF, and the correction of RPF by the percent of hemat-
ocrit value was used as an estimate of the renal blood flow
(RBF). Finally, renal vascular resistances (RVR) were de-
termined by the ratio between mean blood pressure and
RBF.
Renal structure
The animals were anesthetized with an i.p. injection
of ketamine (Imalgene; 60 mg/kg body weight) and xy-
lazine (Rompum; 7.5 mg/kg body weight). After collect-
ing a blood sample, the kidneys were quickly removed,
cleaned of the surrounding fat, washed in phosphate-
buffered saline (PBS), and weighed. A sagittal section
of the right kidney was fixed in phosphate buffered 4%
formaldehyde solution and embedded in paraffin. Sec-
tions were then stained with hematoxylin-eosin, periodic
acid-Schiff (PAS), and periodic acid-silver metenamine
(PASM). For electron microscopy analysis of glomerular
basement membrane (GBM) width, fragments of renal
cortex were fixed in 4% formaldehyde, postfixed in phos-
phate buffered 1% osmium tetroxide, and embedded in
epoxy resin (Agar 100). Ultrathin sections were cut and
stained with uranyl acetate and lead citrate.
Renal morphology was evaluated by 2 independent ob-
servers blinded to the group assignment, as previously re-
ported [24]. Glomerular sclerosis, defined as segmental or
global, was evaluated on∼150 glomerular tuft profiles per
animal and expressed as percent of involved glomeruli.
Tubulointerstitial damage was evaluated using a semi-
quantitative scale (0: absent; 1: <10%; 2: 10–30%; 3: 30–
70%; 4: >70%), and the extension of cortical lesions in
each animal was expressed as the mean value obtained
measuring a whole sagittal section. Morphometric anal-
ysis was performed with the aid of a computer image
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analysis system (LUCIA 4.6; Laboratory Imaging Ltd.,
Prague, Czech Republic). For glomerular morphometry
[24], the areas of 60 glomeruli per animal were measured,
together with the areas occupied by the mesangial matrix,
as identified by dense PASM staining; mean glomerular
tuft area (mGTA) and fractional mesangial area (fMA),
expressed as percent of mGTA, were reported for each
animal. GBM thickness was calculated as the mean value
of the GBM widths measured at 70 to 110 orthogonal-
section points/10 peripheral capillary loops/glomerulus.
For arterial morphometry [11], ∼140 cross-sections per
animal group of intrarenal arteries with diameter <80
lm (corresponding to arterioles and interlobular arter-
ies) were randomly selected at 40× magnification in PAS-
stained sections. The vessel and lumen diameters were
measured, and media thickness was obtained by the for-
mula: (vessel diameter-lumen diameter)/2. To avoid bias
due to sectioning vessels at various angles, the elliptic pro-
files were measured at the widest part of the shortest di-
ameter. Percent of vessel diameter occupied by media and
lumen, media to lumen ratio, and media cross-sectional
area were also calculated.
Glomerular ECM and TGF-b gene expression
Glomeruli were isolated from the left kidney cortex
by standard sieving techniques, then total RNA was ex-
tracted by the guanidine thiocyanate-phenol-chloroform
method using Trizol (Invitrogen Italia SRL, San Giu-
liano Milanese, Milan, Italy), and the purity of RNA
preparation was confirmed by an absorbance 260:280 ra-
tio >1.9.
Transcript level was measured by competitive reverse
transcription-polymerase chain reaction (RT-PCR) [24].
One lg of total RNA was reverse transcribed using Ret-
roscript kit (Ambion, Austin, TX, USA). The following
primers were used: fibronectin sense 5′-AGC-GGT-
GTG-GTC-TAC-TCT-GT-3′, antisense 5′-GAT-GCA-
CTG-ATC-TCG-GAF-CT-3′; laminin B1 sense 5′-TGT-
CAG-TCA-CCT-GCA-GGA-TG-3′, antisense 5′-CAG-
GAT-CCA-GCA-CAC-GAT-AG-3′; collagen IV a1
chain sense 5′-TCG-GCT-ATT-CCT-TCG-TGA-TG-3′,
antisense 5′-TCT-CGC-TTC-TCT-CTA-TGG-TG-3′;
TGF-b1 sense 5′-ATA-CAG-GGC-TTT-CGC-TTC-
AG-3′, antisense 5′-GTC-CAG-GCT-CCA-AAT-GTA-
GG-3′; b-actin (for normalization) sense 5′-TCT-AGG-
CAC-CAA-GGT-GTG-3′, antisense 5′-TCA-TGA-
GGT-AGT-CCG-TCA-GG-3′. Competitive PCR was
performed by using increasing amounts of mutants made
by creating a deletion in the original PCR product, and
preliminary experiments were performed to establish the
range of mutant concentrations, producing a slope of the
line close to one and within which the equivalence point
falls. After electrophoresis of PCR products, the ratio
of unknown cDNA/mutant was quantified by scanning
densitometry using the ImageJ software, a public domain
Java image processing program inspired by NIH Image,
developed at NIH (Bethesda, MD, USA), and results
were expressed as the ratio of each target to b-actin
mRNA level.
Glomerular cell and retinal microvascular apoptosis
Glomerular cell apoptosis was assessed by immuno-
histochemistry for active caspase-3. Briefly, paraffin-
embedded sections (4-lm thick) were deparaffinized in
xylene and rehydrated in ethanol and treated with 0.1%
Triton-X100 for 10 minutes. Then, endogenous peroxi-
dase activity was quenched by incubating sections in 2%
(v/v) hydrogen peroxide in PBS for 30 minutes, whereas
nonspecific binding was blocked by incubation in 10%
normal goat serum (Sigma) for 45 minutes at room tem-
perature. A rabbit polyclonal antibody against the ac-
tive form of caspase-3 (Anti-ACTIVE Caspase-3 pAb;
Promega Italia, Milan, Italy) was then applied to sec-
tions at a concentration of 1:200 overnight at 4◦C. Af-
ter 3 5-minute washings with 0.1% bovine serum albu-
min (BSA) in PBS, sections were incubated for 1 hour at
room temperature with 1:300 diluted biotinylated goat-
antirabbit IgG antibody (Dako, Glostrup, Denmark),
followed by 30-minute incubation with streptavidine-
biotin-peroxidase complex. Then, sections were devel-
oped with 3,3′-diaminobenzidine in chromogen solution
(Liquid DAB+; Dako) for 4 minutes and counterstained
with hematoxylin. In the negative controls, the primary
antibody was omitted. Sections of thymus and small intes-
tine were used as positive controls. The number of total
and positive cells in 100 glomeruli was counted, and the
results were expressed as percent of active caspase-3 pos-
itive cells.
For the assessment of retinal microvascular apoptosis,
the eyes were removed, rinsed in PBS, and immersed in
buffered 10% formaldehyde solution. The whole retina
was isolated and digested as previously reported [20]. Cell
death in trypsin digests was detected with the terminal de-
oxynucleotidyl transferase-mediated d-UTP-biotin nick
end labelling (TUNEL) method [20], using the In Situ
Cell Death Detection Kit (Boheringer Mannheim Italia,
Milan, Italy). Briefly, the specimens were permeabilized
with 0.5% Triton X-100 in PBS for 1 hour at room temper-
ature, then incubated with TUNEL reagents for 1 hour at
37◦C and mounted in Slow-Fade (Molecular Probes, Eu-
gene, OR, USA). In each experiment, a negative control,
without the terminal transferase, and a positive control,
pretreated with DNase I (1 lg/mL in 40 mmol/L Tris-HCl,
6 mmol/L MgCl2 buffer, pH 7.5) for 10 minutes at room
temperature, were included. Identification of TUNEL+
cells was performed blinded by surveying systematically
each slide under an Eclipse E600 fluorescence micro-
scope (Nikon Europe, Badhoevedorp, The Netherlands).
Specimens were stained with PAS and hematoxylin, and
the morphologic counterparts of TUNEL+ images were
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Table 1. Metabolic and cardiovascular parameters—Final body weight, nonfasting blood glucose, and glycated hemoglobin (Hb) levels and mean
blood pressure (BP) in time 0 (0) Milan normotensive strain (MNS), Milan hypertensive strain (MHS), and Wistar (WS) rats, and diabetic (D3
and D6) and age-matched nondiabetic (ND3 and ND6) MNS, MHS, and WS rats at 3 months and 6 months of disease duration
Final body Nonfasting blood Glycated Mean BP
Group weight g glucose mmol/L Hb % mm Hg
MNS-0 336 ± 25 (9) 6.3 ± 0.8 (9) 5.1 ± 0.9 (9) 95.6 ± 2.4 (4)
MHS-0 339 ± 32 (9) 6.4 ± 0.5 (9) 5.1 ± 0.9 (9) 133.7 ± 4.5 (4)b
WS-0 330 ± 18 (8) 6.4 ± 0.7 (8) 5.1 ± 0.4 (8) NA
MNS-ND3 470 ± 29 (8) 6.4 ± 0.6 (8) 5.2 ± 0.9 (8) 94.9 ± 3.5 (6)
MNS-D3 370 ± 39 (8)a 25.2 ± 2.5 (8)a 15.4 ± 1.5 (8)a 94.8 ± 5.1 (6)
MHS-ND3 473 ± 50 (8) 6.4 ± 0.5 (8) 5.2 ± 1.0 (8) 137.3 ± 5.9 (6)b
MHS-D3 364 ± 41 (9)a 25.7 ± 3.3 (9)a 15.7 ± 1.4 (9)a 138.1 ± 11.7 (6)b
MNS-ND6 552 ± 24 (14) 6.3 ± 0.5 (14) 5.4 ± 0.8 (14) 94.3 ± 2.7 (6)
MNS-D6 345 ± 52 (12)a 26.3 ± 2.4 (11)a 15.5 ± 2.1 (11)a 94.4 ± 2.4 (6)
MHS-ND6 558 ± 28 (14) 6.3 ± 0.6 (14) 5.5 ± 1.0 (14) 140.5 ± 4.0 (6)b
MHS-D6 337 ± 47 (14)a 26.6 ± 2.6 (14)a 15.7 ± 3.1 (17)a 139.8 ± 4.5 (6)b
WS-ND6 558 ± 78 (10) 6.3 ± 0.3 (10) 5.5 ± 0.4 (10) NA
WS-D6 354 ± 40 (14)a 26.3 ± 2.1 (14)a 15.5 ± 1.1 (14)a NA
NA, not assessed. Mean ± SD. N shown in parentheses. Significantly different from the corresponding nondiabetic rats at aP < 0.00,1 and from the corresponding
MNS rats at bP < 0.001.
identified as endothelial cells, pericytes or, in the case of
cells with small size or uninformative shape or topogra-
phy, undetermined cells.
Statistical analysis
Values were expressed as mean ± SD and, for pro-
teinuria, also as median value; the percent change versus
control was also calculated. Statistical significance was
evaluated by one-way analysis of variance (ANOVA),
followed by the Student-Newman–Keuls test for multi-
ple comparisons. For proteinuria that showed a nonpara-
metric distribution of values, differences among groups
were analyzed by the Kruskal-Wallis test followed by
the Mann-Whitney U test for pairwise comparisons. A
P value < 0.05 was considered significant. All tests were
performed on raw data.
RESULTS
Metabolic and cardiovascular parameters
Diabetes-induced impairment of body growth, as well
as increases in blood glucose, glycated hemoglobin
(Table 1), and urine volume (Fig. 1A) were similar in
the 3 rat strains. Mean weekly insulin requirement was
similar among the diabetic MNS (2.95 ± 0.34 IU), MHS
(2.99 ± 0.29 IU), and WS (2.88 ± 0.34 IU) rats.
Blood pressure was normal in the MNS (∼120–80 mm
Hg) and elevated in the MHS (∼170–120 mm Hg)
throughout the study, and was unaffected by diabetes
(Table 1). Heart rate did not differ between MNS and
MHS animals (309 ± 33 vs. 314 ± 11 beats/min), and was
not influenced by diabetes in both strains (315 ± 30 and
310 ± 44 beats/min, respectively).
Renal function
Proteinuria was similar in the 3 rat strains at time 0.
In MNS rats, it increased progressively with time (35-
fold increment at 6 months vs. time 0), with no significant
difference between diabetic and nondiabetic MNS (me-
dian value 707.1 and 658.0 mg/24 h, respectively). In WS
rats, proteinuria increased only in the diabetic animals,
though to a much lesser extent than in the MNS, with a
∼5-fold increase versus time 0 and 6-month nondiabetic
animals (median value 93.3 vs. 19.6 and 23.5 mg/24 h).
Conversely, this parameter did not change, either with
time or diabetes, in MHS rats; thus, values detected in
these animals were significantly lower than those of non-
diabetic MNS, diabetic MNS, and diabetic WS rats at all
time points after 0 (Fig. 1B).
Serum creatinine was also similar in the 3 rat strains at
time 0, and increased by ∼70% in the MNS at 6 months,
with no difference between diabetic and nondiabetic ani-
mals, whereas it did not change in MHS and WS rats, both
diabetic and nondiabetic (Fig. 1C). Accordingly, 6-month
creatinine clearance was reduced (by ∼50% vs. time 0
values) in both diabetic and nondiabetic MNS rats, but
not in MHS and WS rats. At 1.5 months, this GFR es-
timate was significantly increased (by ∼30%) in diabetic
MNS and WS, but not MHS rats versus the corresponding
nondiabetic controls (Fig. 1D). At the same time point,
assessment of GFR by inulin clearance showed increased
values (by 22%) in diabetic MNS, but not MHS rats versus
the corresponding nondiabetic animals. Increased GFR
in diabetic MNS rats was associated with increased FF
(by 24%) and kidney weight (by 28%), without any sig-
nificant change in RPF and RVR. RVR was more pro-
nounced in MHS rats, both diabetic and nondiabetic, than
in matched MNS animals (Table 2)
Renal structure
At morphologic examination, the histologic appear-
ance of kidney tissue was very homogeneous within each
group. No sign of glomerular disease was detected in the 3
Pugliese et al: Hemodynamic vs. metabolic factors in diabetic nephropathy 1445
0
50
100
150
200
250
300
Ur
in
e 
vo
lu
m
e,
 
m
L/
24
 h
0 1.5 3 4.5 6
Months
*
*
*
*
A
0 1.5 3 4.5 6
Months
0
10
20
30
40
50
60
Se
ru
m
 c
re
a
tin
in
e,
 
µm
o
l/L
*
C
0 1.5 3 4.5 6
Months
0
0.25
0.50
0.75
1.00
1.25
1.50
Cr
ea
tin
in
e 
cle
ar
en
ce
,
m
L/
m
in
*
†
D
0 1.5 3 4.5 6
Months
0
200
400
600
800
1000
Pr
ot
ei
nu
ria
, m
g/
24
 h
*
*
*
*
†††
B
Fig. 1. Renal function. Urine volume (mL/24
h) (A), proteinuria (mg/24 h) (B), serum crea-
tinine (lmoL/L) (C), and creatinine clearance
(mL/min) (D) in diabetic (dashed lines) and
age-matched nondiabetic (closed lines) Milan
normotensive strain (MNS, triangles), Milan
hypertensive strain (MHS, circles), and Wistar
(WS, squares) rats at 0, 1.5, 3, 4.5, and 6 months
of disease duration. Mean ± SD; the N for
urine volume and proteinuria was: 25 for all
groups at time 0; 19 to 22 at 1.5 and 3 months,
and 12 to 14 at 4.5 and 6 months for MNS rats;
21 to 23 at 1.5 and 3 months, and 14 at 4.5 and 6
months for MHS rats; and 10 to 14 at 1.5, 3, 4.5,
and 6 months for WS rats; the N for serum cre-
atinine and creatinine clearance was: 8 to 9 at
time 0; 6 to 8 at 1.5 months; 8 to 9 at 3 months;
10 to 14 at 6 months. (A) ∗significantly dif-
ferent at P < 0.001 in the diabetic rats from
all 3 strains versus the corresponding nondia-
betic animals; (B) ∗significantly different at P
< 0.001 in the diabetic and nondiabetic MNS
versus MHS and WS rats, and † in the dia-
betic WS versus nondiabetic WS and diabetic
and nondiabetic MHS rats; (C) ∗significantly
different at P < 0.001 in the diabetic and non-
diabetic MNS versus MHS and WS rats; (D)
∗significantly different at P < 0.001 in the dia-
betic MNS and WS rats versus the correspond-
ing nondiabetic animals and the diabetic and
nondiabetic MHS rats, and † in the diabetic
and nondiabetic MNS versus MHS and WS
rats.
Table 2. Renal hemodynamics—Kidney weight, GFR, filtration fraction (FF), renal plasma flow (RPF), and renal vascular resistances (RVR) in
diabetic (D) and age-matched nondiabetic (ND) Milan normotensive strain (MNS) and Milan hypertensive strain (MHS) rats at 1.5 months of
disease duration
Kidney GFR RPF RVR
Group weight g mL/min FF mL/min mm Hg/mL/min
MNS-ND 2.42 ± 0.31 (6) 3.35 ± 0.43 (6) 24.63 ± 5.09 (6) 13.88 ± 2.07 (6) 4.79 ± 0.70 (6)
MNS-D 3.08 ± 0.31 (6)a 4.10 ± 0.33 (6)a 30.63 ± 0.80 (6)a 13.39 ± 1.30 (6) 5.04 ± 0.59 (6)
MHS-ND 2.38 ± 0.14 (6) 3.06 ± 0.77 (6) 24.18 ± 4.40 (6) 12.66 ± 2.32 (6) 6.59 ± 1.72 (6)d
MHS-D 2.53 ± 0.55 (6) 3.43 ± 0.31 (6)c 25.30 ± 1.12 (6)b 13.66 ± 1.51 (6) 6.20 ± 0.86 (6)
Mean ± SD. N shown in parentheses. Significantly different from the corresponding nondiabetic rats at aP < 0.01 and from the corresponding MNS rats at bP <
0.001, cP < 0.01, or dP < 0.05.
strains at time 0, and in MHS rats at both 3 and 6 months,
whereas MNS rats, both nondiabetic and diabetic, and to
a lesser extent diabetic WS (but not nondiabetic WS) rats
showed clear evidence of glomerular disease, particularly
at the end of the 6-month period (Fig. 2).
Morphometric analysis did not show significant differ-
ences between MNS and MHS rats at time 0, with similar
values for kidney weight (2.30 ± 0.18 vs. 2.29 ± 0.18 g),
mGTA (5636 ± 598 vs. 5926 ± 280 lm2), fMA (3.30 ±
1.31 vs. 3.43 ± 0.60%), and GBM width (159 ± 7 vs. 161
± 21 nm). At this same time point, glomerular sclero-
sis and tubulointerstitial damage were virtually absent.
A similar picture was found in WS rats (not shown).
At 6 months, nondiabetic MNS rats showed unchanged
mGTA and significantly increased fMA (by 79%), GBM
width (by 40%), and kidney weight (by 36%) compared
to time 0 MNS rats. Glomerular sclerosis (∼20%) and
tubulointerstitial damage (scoring ∼2) were also present
in these animals. Diabetic MNS rats showed increased
mGTA (+24%) and a further increment of kidney weight
(+52%), fMA (+72%), and GBM thickness (+23%),
but not glomerular sclerosis and tubulointerstitial dam-
age versus nondiabetic MNS rats (Fig. 3). At variance
with the MNS, MHS rats showed no renal disease, as
assessed by the above morphometric parameters, even
after 6 months of uncontrolled diabetes (Fig. 3). On the
contrary, diabetes produced significant kidney damage in
WS rats; at 6 months, diabetic WS showed increased kid-
ney weight (+29%), glomerular sclerosis (+95%), tubu-
loinsterstitial damage (+179%), fMA (+71%), and GBM
thickness (+12%), but not mGTA versus nondiabetic WS
rats (Fig. 3).
At time 0, a significant increment of media cross-
sectional area (369.4 ± 215.1 vs. 315.1 ± 158.9, P < 0.01)
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Fig. 2. Renal structure. Renal histologic appearance in representative time 0 Milan normotensive strain (MNS, A), Milan hypertensive strain
(MHS, D), and Wistar (WS, G) rats, and nondiabetic and diabetic MNS (B and C), MHS (E and F), and WS (H and I) rats at 6 months of disease
duration (Periodic acid–Schiff, 100× magnification).
was detected in MHS versus MNS rats. At 6 months, me-
dia thickness was increased (by 11%), whereas lumen
diameter was reduced (by 7%) in nondiabetic MHS ver-
sus MNS rats. Diabetes did not affect these values in
MHS rats, whereas it reduced media thickness (by 11%)
and increased lumen diameter (by 13%) in the MNS
versus the corresponding nondiabetic controls. Percent
media/vessel and lumen/vessel and media to lumen ratio
changed accordingly (Table 3).
Glomerular ECM and TGF-b gene expression
Transcripts for ECM and TGF-b1 were similar in the
2 rat strains at time 0, and increased with age in the MNS
(by 23–38% at 6 months vs. time 0, P < 0.001), but not
MHS rats.
Higher mRNA levels were detected in diabetic ver-
sus nondiabetic MNS rats at both 3 months (fibronectin
+38%, laminin B1 +36%, collagen IV a1 chain +29%,
and TGF-b1 +28%) and 6 months (with maximal in-
creased observed for collagen IV, +52%) of disease du-
ration. No significant increase was observed in diabetic
versus nondiabetic MHS rats at any time point (Fig. 4).
Glomerular cell and retinal microvascular apoptosis
At 6 months, significant glomerular cell apoptosis was
detected only in MNS rats, both nondiabetic and diabetic
(0.620 ± 0.091 vs. 0.698 ± 0.103%). Conversely, very rare
active caspase-3 positive cells were detected in glomeruli
from MHS rats, with no significant difference between
nondiabetic and diabetic (0.151 ± 0.028% vs. 0.188 ±
0.045%).
At the same time point, virtually no apoptosis was
detected in the retinal microvessel preparations from
nondiabetic MNS rats, whereas an increased cell death
rate was observed in specimens from diabetic MNS rats,
though differences were not statistically significant. In
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Fig. 3. Renal structure. Kidney weight (g) (A), glomerular sclerosis (%) (B), tubulointerstitial damage (score) (C), glomerular area (lm2 × 103) (D),
mesangial fractional area (%) (E), and glomerular basement membrane (GBM) width (nm) in diabetic (black bars) and age-matched nondiabetic
(white bars) Milan normotensive strain (MNS), Milan hypertensive strain (MHS), and Wistar (WS) rats at 6 months of disease duration. Mean ±
SD; N= 6 per group/time point. Significantly different at ∗P < 0.001, †P < 0.01, or ‡P < 0.05 versus the corresponding nondiabetic rats; §P < 0.001
or ‖P < 0.01 versus the corresponding MNS rats; and #P < 0.001 or ¶P < 0.01 versus the corresponding WS rats.
Table 3. Arterial structure—Vessel diameter, media/lumen, media width, media/vessel, lumen diameter, and lumen/vessel of arterioles and
interlobular arteries in diabetic (D) and age-matched nondiabetic (ND) Milan normotensive strain (MNS) and Milan hypertensive strain (MHS)
rats at 6 months of disease duration
Vessel diameter Media/lumen Media width Media/vessel Lumen diameter Lumen/vessel
Group lm ratio lm % lm %
MNS-ND 25.7 ± 8.3 0.75 ± 0.26 7.6 ± 2.8 29.4 ± 3.7 10.6 ± 3.7 41.3 ± 7.3
(146) (146) (146) (146) (146) (146)
MNS-D 25.4 ± 8.7 0.64 ± 0.28 6.7 ± 2.5 26.8 ± 5.3 12.0 ± 5.6 46.4 ± 10.6
(133) (133)a (133)b (133)a (133)a (133)a
MHS-ND 26.6 ± 8.7 0.93 ± 0.35 8.4 ± 3.1 31.6 ± 4.0 9.8 ± 3.8 36.9 ± 8.0
(148) (148)c (148)d (148)c (148) (148)c
MHS-D 26.7 ± 8.9 0.93 ± 0.46 8.4 ± 3.0 31.4 ± 4.7 10.1 ± 4.4 36.9 ± 9.0
(149) (149)c (149)c (149)c (149)c (149)c
Mean ± SD of all vascular profiles per each animal group. N shown in parentheses.
Significantly different from the corresponding nondiabetic rats at aP < 0.001 or bP < 0.01, and from the corresponding MNS rats at cP < 0.001 or dP < 0.05.
nondiabetic MHS rats, the positivity of TUNEL reaction
was also increased compared to nondiabetic MNS, again
not significantly, with values in nondiabetic MHS similar
to those detected in diabetic MNS rats. Finally, diabetic
MHS rats showed markedly increased cell death levels
compared to all the other groups.
Endothelial cells accounted for most of changes, show-
ing a step-wise increase in apoptosis upon addition of
diabetes and hypertension, similar to that observed in
total cells; conversely, no significant change in pericyte
death rate was detected in response to either diabetes or
hypertension (Fig. 5).
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Fig. 4. Glomerular ECM and TGF-b gene
expression. Glomerular mRNA levels of fi-
bronectin (A), laminin B1 (B), collagen IV a1
chain (C), and TGF-b1 (D) (expressed as opti-
cal density ratio to b-actin mRNA level) from
diabetic (black bars) and age-matched nondi-
abetic (white bars) Milan normotensive strain
(MNS) and Milan hypertensive strain (MHS)
rats at 0, 3, and 6 months of disease duration.
Mean ± SD; N= 6 per group. Significantly
different at ∗P < 0.001 or †P < 0.01 versus
the corresponding nondiabetic rats; and ‡P <
0.001, §P < 0.01 or ‖P < 0.05 versus the cor-
responding MNS rats.
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Fig. 5. Retinal microvascular apoptosis.
Number of TUNEL+ endothelial cells (A),
pericytes (B), undetermined cells (C), and
total cells (D) per whole retina in diabetic
(black circles) and age-matched nondiabetic
(white circles) Milan normotensive strain
(MNS) and Milan hypertensive strain (MHS)
at 6 months of disease duration. Individual
rat values; gray bar = mean value per each
animal group. Significantly different at ∗P <
0.001 in diabetic MHS rats versus the other 3
groups.
DISCUSSION
In this study, nondiabetic MNS rats developed with age
a focal and segmental glomerulosclerosis with marked
proteinuria and increased glomerular ECM and TGF-
b mRNA levels, whereas nondiabetic MHS rats did not
show any change in renal function and structure, in keep-
ing with previous reports on this animal model [11, 17].
Induction of diabetes in MNS rats resulted in typical le-
sions superimposed onto age-dependent glomeruloscle-
rosis, and a further up-regulation of glomerular ECM and
TGF-b gene expression. Diabetes also produced signifi-
cant changes in renal function and structure in WS rats of
the same order of magnitude of those observed in other
diabetic rodents [21, 24], but less pronounced than in
MNS rats. On the contrary, chronic hyperglycemia was
not associated with significant renal hypertrophy and in-
jury in MHS rats, in contrast with human studies showing
that arterial hypertension is a progression factor for di-
abetic nephropathy [25]. Renal hemodynamic changes
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characteristic of diabetes occurred in diabetic MNS (and,
as suggested by the increased creatinine clearance, in
WS), but not in diabetic MHS rats. Augmented FF with-
out changes in RPF and RVR indicated an increase of
efferent/afferent resistance with consequent increment
of glomerular capillary pressure, driving enhanced GFR.
Alternatively, increased GFR might be dependent on an
increase in glomerular ultrafiltration coefficient, which
previous micropuncture studies in diabetic rats failed to
show, both in filtration pressure equilibrium and disequi-
librium [8, 26, 27]. A definite explanation of the normal
values of RPF observed in diabetic MNS rats in pres-
ence of renal hyperfiltration is not available. Although
several studies describe a rise in RPF during hyperfiltra-
tion, other authors suggest that this phenomenon could
be strain-dependent, since it was lacking in the sponta-
neously hypertensive rat (SHR) made diabetic by strep-
tozotocin, despite the significant increase in GFR [28].
A further possibility is that the rise in RPF was not evi-
dent yet at time of our observation. Morphometric anal-
ysis confirmed the thickening of the media layer (and
corresponding narrowing of the lumen) in MHS versus
MNS rats at the level of the interlobular arteries [11], and
showed that this alteration occurred also at the arteriolar
level. Diabetes induced a reduction of media width and
an increment of lumen diameter in MNS, but not MHS
rats.
At variance with renal parameters, including glomeru-
lar cell apoptosis, retinal microvascular apoptosis was in-
fluenced profoundly by arterial hypertension, with a more
pronounced death rate detected in diabetic MHS rats,
mainly accounted for by endothelial cells. This is consis-
tent with human studies indicating that hypertension is
an important risk factor for diabetic retinopathy [29]. Di-
abetes produced more subtle effects than hypertension,
as previously reported in diabetic rats of comparable dis-
ease duration [30]. The different behavior of endothelial
cells and pericytes in response to diabetes (and hyperten-
sion) is also in keeping with previous studies, indicating
differences in the molecular mechanisms underlying cell
death in these 2 cell types [31].
These data point to the individual predisposition, pos-
sibly genetically determined, as a major risk factor for the
development of diabetic nephropathy. The importance of
genetic predisposition is supported by the acceleration of
glomerular disease in diabetic MNS, as well as the fail-
ure of MHS rats to develop proteinuria and glomerular
lesions, even after 6 months of diabetes, thus suggesting
that both susceptibility and protection factors may influ-
ence the occurrence of renal damage. This is in agreement
with previous reports showing a familiar distribution of
this complication in diabetic subjects [3] and the suscep-
tibility of several rodent strains to renal disease associ-
ated with aging [13], diabetes [32], and uninephrectomy
[33].
Our paper also suggests that susceptibility in the MNS,
and protection in the MHS, may be dependent on differ-
ent mechanisms. Previous reports from our group showed
an age-dependent increase in ECM production and pro-
liferative response to serum in mesangial cells from MNS,
but not MHS rats [34], and a more marked matrix ac-
cumulation stimulated by high glucose in MNS versus
MHS mesangial cells [35], indicating a genetically deter-
mined hyper-responsiveness to sclerosing stimuli in the
glomerulosclerosis-prone strain. In addition, the detec-
tion of podocyte changes in this strain [36] suggests a
yet unidentified defect, possibly genetic, at this level. On
the other hand, the postulated, genetically determined
hemodynamic protection of MHS rats toward increased
systemic blood pressure might also be responsible for
their resistance to diabetic nephropathy, although other
genetic mechanisms independent of hemodynamics, and
possibly involving a reduced mesangial cell response
to sclerosing stimuli [34, 35], cannot be ruled out. The
hemodynamic nature of protection from both hyperten-
sive and diabetic renal injury in the MHS is consistent
with the demonstration that the extent of glomerular in-
jury in experimental models of arterial hypertension is
related to glomerular capillary pressure and, inversely,
to preglomerular resistances [37]. In fact, an increment
of preglomerular resistance would block transmission
of systemic hypertension to the glomerular circulation,
thus protecting it from the injurious effect of mechanical
stretch.
The increase of preglomerular resistance in the MHS
is indicated by the increased total peripheral resistance
[38] and RVR, and unchanged single nephron GFR
and glomerular capillary pressure [39] compared to the
MNS rats. The lack of glomerular hypertension in the
absence of diabetes in both strains indicates that spon-
taneous glomerulosclerosis of MNS rats is not hemo-
dynamically mediated, as previously reported [11, 14],
and that the marked hypertrophy of intrarenal arteries
could account for the increased preglomerular resistance
in the MHS rats, although the enhanced tubuloglomeru-
lar feedback sensitivity may also play a role [40]. These
functional and/or structural abnormalities of intrarenal
arteries could also have prevented the loss of blood flow
autoregulation induced by hyperglycemia in the MHS,
and produced the paradox of lower glomerular capillary
pressure in the hypertensive MHS than in the normoten-
sive MNS (and WS) rats. This is supported by the ob-
servation that typical hemodynamic changes induced by
diabetes occurred in diabetic MNS (and WS), but not
MHS rats. In fact, the increased creatinine clearance,
GFR, and FF detected in diabetic MNS animals suggest
glomerular hypertension likely resulting from diabetes-
induced dilation of intrarenal arteries and arterioles, as
indicated by the increment of lumen diameter with re-
duction of media thickness. Conversely, the unchanged
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creatinine clearance, GFR, FF, and RVR in diabetic ver-
sus nondiabetic MHS rats suggest that hypertrophic in-
trarenal arteries and possibly arterioles are resistant to
dilation induced by diabetes, and eventuating in loss of
autoregulation, as indicated also by the lack of variation
in media width and lumen diameter. Unfortunately, the
lack of superficial glomeruli in these rat strains (and their
blood pressure instability during the micropuncture pro-
cedure) did not allow the direct assessment of glomerular
capillary pressure, and indirect methods based on stop-
flow techniques are not sufficiently reliable [19]. In addi-
tion, renal hypertrophy due to expanded nephron size,
and commonly associated with (and possibly causally
linked to) renal hemodynamic changes [40], was detected
in the diabetic MNS (and WS), but not MHS rats. The
importance of hemodynamics is also suggested by the
opposite picture observed in the retinal microcirculation
that was damaged more markedly in diabetic MHS ver-
sus MNS rats due to the apparent lack of autoregula-
tory mechanisms protecting from systemic hypertension.
It is also noteworthy that the cell death rate detected
at the glomerular level was completely different from
that observed in retinal microvessel preparations, with
much more pronounced apoptosis in the MNS than in
the MHS groups. In contrast to the MHS, other mod-
els of genetic hypertension, such as the SHR [41] and
Dahl salt-sensitive rat [42], develop progressive protein-
uria and renal injury, which are accelerated by diabetes
[43, 44], as in other models of experimentally induced ar-
terial hypertension [45, 46]. The comparison of our data
on MHS rats with those obtained in the SHR and Dahl
salt-sensitive rat provides further support to the “hemo-
dynamic” hypothesis. In fact, both the MHS and SHR
are characterized by enhanced autoregulation due to wall
hypertrophy and lumen narrowing of preglomerular re-
sistance vessels (interlobular and arcuate arteries and af-
ferent arterioles) that appear to be primary because they
precede [11, 47] and possibly cause [48] the development
of hypertension. The resulting increased preglomerular
resistance is likely to hinder extension of systemic hy-
pertension to the glomerular capillaries, thus protecting
against the development of glomerulosclerosis. This pro-
tection is maintained throughout life in the MHS [11, 15],
but not in the SHR, which develops glomerular disease
at approximately 1 year of age [41]. This is supported by
the observation of increased RVR and unchanged sin-
gle nephron GFR and glomerular capillary pressure in
the MHS [39] and young SHR [49], but not in the older
SHR (prior to the development of renal disease), show-
ing glomerular hypertension mainly dependent on a de-
cline of preglomerular resistance that is due to reduced
intrinsic myogenic response [50]. At variance with the
SHR, impaired (dynamic) myogenic autoregulation [51]
and glomerular hypertension [52] occur much earlier in
the Dahl salt-sensitive rat, despite the presence of struc-
tural changes of preglomerular resistance vessels [53, 54],
with hypertrophy, however, that does not result in lumen
narrowing [55]. This is consistent with the occurrence of
progressive glomerular injury, which is more extensive
and develops more rapidly than in the SHR [42].
Taken together, our results support the concept that
diabetes-induced hemodynamic changes resulting in
glomerular hypertension are essential for the biochem-
ical and metabolic consequences of hyperglycemia to
produce significant glomerular lesions. Several in vitro
studies have demonstrated that both high glucose and
stretching are capable of producing mesangial cell dys-
function with a similar pattern of alteration of cell and
matrix turnover and cytokine production [5, 6], partic-
ularly the up-regulation of ECM and TGF-b produc-
tion [56–59]. Thus, the permissive role of hemodynamic
changes toward the injurious effects of hyperglycemia
would consist in a (quantitative) potentiation of these ef-
fects, though a (qualitatively) different effect of increased
capillary pressure on the glomerular circulation cannot be
excluded. This hypothesis is confirmed by our finding that
glomerular ECM and TGF-b gene expression increased,
both with age and diabetes, in MNS, but not MHS rats.
CONCLUSION
Our results further support the hypothesis that hy-
perglycemia is essential, but not sufficient, for diabetic
glomerular sclerosing lesions to occur, unless acting on a
(genetically) predisposed ground. These data also suggest
that the occurrence of hemodynamic changes is required
for the development of diabetic nephropathy by exerting
a permissive role toward hyperglycemia-induced injury.
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